Investment analysts at Wall Street Zen began coverage on shares of SenesTech (NASDAQ:SNES – Get Free Report) in a research note issued on Wednesday. The firm set a “sell” rating on the stock.
SenesTech Price Performance
Shares of NASDAQ SNES opened at $2.68 on Wednesday. SenesTech has a 1-year low of $1.30 and a 1-year high of $7.82. The business has a 50-day moving average of $2.13 and a 200-day moving average of $2.63. The company has a debt-to-equity ratio of 0.05, a current ratio of 6.32 and a quick ratio of 4.92. The company has a market capitalization of $4.76 million, a price-to-earnings ratio of -0.35 and a beta of -0.21.
SenesTech (NASDAQ:SNES – Get Free Report) last issued its earnings results on Thursday, May 8th. The company reported ($1.28) earnings per share for the quarter. SenesTech had a negative return on equity of 150.33% and a negative net margin of 403.51%. The company had revenue of $0.49 million during the quarter. On average, equities analysts anticipate that SenesTech will post -10.22 EPS for the current fiscal year.
About SenesTech
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Recommended Stories
- Five stocks we like better than SenesTech
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Turbulence for Joby Shares: What’s Behind the Recent Dip?
- Trading Stocks: RSI and Why it’s Useful
- Why Carnival Could Be the Ultimate Non-Tech Growth Stock
- How to Invest in Biotech Stocks
- Super Micro Computer Stock Clears New Path Higher on Saudi Orders
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.
